Oct 22, 2026 08:01AM
Oct 22, 2026 08:00AM
Oct 19, 2026 08:00AM
Oct 19, 2026 08:00AM
Sep 15, 2026 09:00AM
Aug 27, 2026 05:47PM
Aug 27, 2026 05:47PM U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens
Aug 24, 2026 06:31AM
Aug 24, 2026 06:31AM
Aug 4, 2026 04:01PM
Aug 4, 2026 04:01PM
Jul 24, 2026 06:26AM
Jul 24, 2026 06:26AM
Jul 21, 2026 10:00AM Gilead to present lenacapavir HIV trial data at AIDS 2026
Jul 21, 2026 10:00AM
Jul 21, 2026 10:00AM
Jul 21, 2026 10:00AM
Jun 24, 2026 04:29PM
Jun 24, 2026 04:29PM
Jun 24, 2026 08:30AM
Jun 23, 2026 07:45AM EU approves Gilead's Trodelvy for first-line metastatic TNBC
Jun 23, 2026 07:45AM
Jun 16, 2026 07:05AM
Jun 15, 2026 04:34PM
Jun 15, 2026 04:34PM
Jun 8, 2026 04:35PM
Jun 8, 2026 04:35PM
Jun 8, 2026 04:30PM Merck and Gilead discontinue lung cancer drug combination trial
Jun 8, 2026 04:30PM
Jun 4, 2026 04:15PM
Jun 4, 2026 04:15PM
Jun 2, 2026 08:30AM
Jun 2, 2026 08:30AM
May 27, 2026 02:00AM
May 27, 2026 02:00AM Phase 3 ASSURE Interim Data: Majority of People in the Study with ALP 1–1.67×ULN Achieved High and Sustained Composite ALP Normalization at 24 Months with Gilead’s Livdelzi (Seladelpar)
May 22, 2026 02:00PM
May 22, 2026 02:00PM
May 22, 2026 01:42PM
May 22, 2026 07:47AM
May 22, 2026 07:47AM
May 21, 2026 05:00PM
May 13, 2026 08:30AM Gilead to present 29 abstracts on liver disease treatments at EASL 2026
May 13, 2026 08:30AM
May 7, 2026 04:01PM
Apr 29, 2026 08:30AM
Apr 29, 2026 08:30AM
Apr 28, 2026 08:45AM
Apr 28, 2026 08:45AM
Apr 14, 2026 12:03PM PEPFAR and Global Fund expand lenacapavir access to 1 million more people
Apr 14, 2026 12:00PM

335,176 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All